Philips updates microphone for Nuance Dragon NaturallySpeaking

Justine Varieur Cadet | | Health Imaging | Artificial Intelligence
Royal Philips Electronics will equip its dictation microphone SpeechMike with SpeechControl, allowing SpeechMike to be used with Nuance's Dragon NaturallySpeaking speech recognition program.

Nuance acquired Philips Speech Recognition Systems in October 2008, adding SpeechMagic to its existing portfolio of original equipment manufacturer solutions, which include Dragon Medical SDK and PowerScribe SDK.

The microphone's function buttons have also been programmed with frequent speech recognition commands, allowing users to start a recording, move the cursor or correct passages at the press of a button, according to the company. Users can also adapt the device to their preferences by assigning functions to various buttons. SpeechControl also supports configuration of the USB foot switch from Philips for use with Dragon NaturallySpeaking.

Phillips said this is part of its strategy to integrate digital speech processing solutions into the workflows of document-critical sectors and to re-establish dictation as a productivity and process.




Justine Varieur Cadet

Related Content

New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA
PHOTO GALLERY: Medical imaging technology at RSNA 2024
Cardiology, radiology specialists debate CCTA’s rise as a go-to imaging modality for CAD
Can large language models break language barriers in radiology reports?
Most patients want to know if AI is involved in their care
New algorithm is twice as accurate at predicting stroke timing compared to the standard of care

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.